IPN01194

· Ipsen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPN01194, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours [Phase 1, Phase 2]